Change in study design and required approval [Regulatives / Guidelines]

posted by docksr – India, 2013-07-10 13:13 (4731 d 20:49 ago) – Posting: # 10969
Views: 4,843

If a three-way crossover design protocol (T1, T2 and R or T with R replicate) with N=X is approved by DCGI for a particular study, and the design is changed to a two-way cross over with >N=X, do we need to seek fresh approval or make necessary amendments to the previously approved protocol


Edit: Please follow the Forum’s Policy. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
106 visitors (0 registered, 106 guests [including 14 identified bots]).
Forum time: 10:03 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5